Latest ERBB Stories

2012-03-02 01:33:11

The main cause of death in women with breast cancer is spread of the original tumor to distant sites, a process known as metastasis.

2010-12-23 08:02:49

Implications for blocking metastasis and improving responses to existing therapies.

2010-07-22 06:00:00

CAMBRIDGE, Mass., July 22 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc.

2010-06-04 14:18:31

MM-111 antibody uses HER2 target to reach and block HER3.

2010-04-30 13:34:00

CAMBRIDGE, Mass., April 30 /PRNewswire/ -- Merrimack Pharmaceuticals' MM-111 Team Leader Charlotte McDonagh, Ph.D., will discuss the development of this novel, bispecific antibody on Tuesday, May 4, at the BIO 2010 International Convention in Chicago, Illinois.

2010-02-22 06:00:00

CAMBRIDGE, Mass., Feb. 22 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc. announced today that the first patient has received an initial dose in a Phase 1/2 clinical study combining MM-121 with Tarceva(®) (erlotinib) in patients with non-small cell lung cancer (NSCLC).

2008-12-12 11:00:00

- Global Phase 3 Program Expected to Begin in December - COLLEGEVILLE, Pa., Dec.

Word of the Day
  • A serpent whose bite was fabled to produce intense thirst.
The word 'dipsas' comes from a Greek word meaning 'thirst'.